National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

mesna
A sulfhydryl compound that is used to reduce the incidence of hemorrhagic cystitis associated with certain chemotherapeutic agents. Mesna is converted to a free thiol compound in the kidney, where it binds to and inactivates acrolein and other urotoxic metabolites of ifosfamide and cyclophosphamide, thereby reducing their toxic effects on the urinary tract during urinary excretion. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:mercaptoethane sulfonate
Mesnum
US brand name:Mesnex
Foreign brand names:Ausobronc
Filesna
Mesnil
Mexan
Mistabron
Mistabronco
Mitexan
Mucofluid
Mucolene
Uromitexan
Ziken
Abbreviation:MSA
Code names:D-7093
UCB 3983
Chemical structure names:
  • 2-mercaptoethanesulfonic acid, sodium salt
  • sodium 2-mercaptoethane sulfonate



Previous:Meprolone, mercaptopurine, Mercaptopurinum, meropenem, Merrem I.V.
Next:Mesnex, mesothelioma tumor lysate-pulsed autologous dendritic cell vaccine, MET receptor tyrosine kinase inhibitor SGX523, Met tyrosine kinase inhibitor BMS-777607, MET tyrosine kinase inhibitor PF-02341066

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov